Phase II pharmacokinetic study to assess the age-dependency in the clearance of doxorubicin in paediatric patients with solid tumours or leukaemia

Beteiligte Wissenschaftler:
Univ.-Prof. Dr. W. Köpcke
Dr. rer. nat. Dipl.-Stat. S. Ligges
Dr. rer. nat. Dipl.-Stat. M. Borowski

Studienleitung:
Univ.-Prof. Dr. med. J. Boos (Kinderonkologie UK Münster)